Trial Profile
ONO-8025 Phase II Study -A Multicenter Randomized Double-blind Study in Chronic Obstructive Pulmonary Disease (COPD) Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Dec 2017
Price :
$35
*
At a glance
- Drugs Imidafenacin (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Ono Pharmaceutical
- 02 Jun 2016 New trial record